Table 14.
Summary of multilevel and logistic regression modeling on blood pressure (systolic and diastolic, SBP and DBP) and total cardiovascular risk (TCVR) outcomes (any occurrence across all studies) (apparent paradoxical results omitted – see Table 13)1
Blood pressure |
TCVR |
||||||
---|---|---|---|---|---|---|---|
BP values at 90 days |
Achieving BP control at 90 days |
Improvement |
Achieving |
||||
SBP | DBP | SBP | DBP | SBP/DBP | In score | Improvement | |
Patient-related variables | |||||||
Demographics | |||||||
Age | − | + | − | + | − | + | |
Male gender | − | + | + | + | |||
Female gender | + | ||||||
Blood pressure | |||||||
SBP at initial diagnosis of hypertension | − | − | − | − | |||
SBP at baseline | − | − | − | − | |||
Controlled SBP at baseline | + | ||||||
DBP at initial diagnosis of hypertension | − | − | |||||
DBP at baseline | − | ||||||
Controlled DBP at baseline | + | ||||||
Uncontrolled DBP at baseline | − | ||||||
Controlled SBP and DBP at baseline | + | + | |||||
Risk factors: general | |||||||
Conditions and risk factors: no pre-existing | + | + | + | + | + | ||
Highly vulnerable to uncontrolled hypertension cluster | − | − | − | − | − | ||
Risk factors: metabolic | |||||||
Diabetes | − | − | − | + | |||
Conditions and risk factors: diabetes | − | − | − | − | |||
Retinopathy | − | ||||||
Obesity | − | − | |||||
Risk factors: cardiovascular | |||||||
Conditions and risk factors: myocardial infarction | − | ||||||
Risk factors: lipids | |||||||
Hypercholesterolemia | − | − | |||||
Total cholesterol at baseline | − | ||||||
Conditions and risk factors: dyslipidemia | − | − | |||||
Risk factors: lifestyle | |||||||
Conditions and risk factors: smoker | - | − | |||||
Total cardiovascular risk | |||||||
Low added risk | + | ||||||
Moderate added risk | − | + | + | ||||
High added risk | + | − | − | + | + | ||
Very high added risk | + | − | − | + | + | ||
Concomitant antihypertensive treatment | |||||||
ACE inhibitor | + | + | |||||
Other concomitant treatment | |||||||
Lipid-lowering | + | ||||||
Medication behavior | |||||||
Nonadherent days in past 4 weeks | − | − | − | − | |||
Patient-reported nonadherence behavior | − | − | − | − | − | ||
Patient-reported adherence behavior | + | ||||||
Patient-rated adherence | + | + | |||||
Physician-rated adherence | + | + | + | + | + | + | + |
Blood pressure monitoring | |||||||
Days since last blood pressure measurement | − | ||||||
Months since last blood pressure measurement | − | − | |||||
Physician-related variables | |||||||
Education | |||||||
Years since medical school graduation (in practice) | − | − | − | − | − | ||
Experience with hypertension | |||||||
Hypertensive patients seen in past 12 months | + | + | + | + | |||
Knowledge regarding hypertension management | |||||||
Correct blood pressure targets for non-diabetic patients | + | + | |||||
Evidence-based practice patterns | |||||||
Self-reported practices consistent with evidence-based guidelines re: SBP threshold for treatment initiation | + | + | + | ||||
Self-reported practices consistent with evidence-based guidelines re: SBP threshold for treatment intensification | + | + | + | ||||
Self-reported practices consistent with evidence-based guidelines re: DBP threshold for treatment initiation | + | + | |||||
Self-reported practices consistent with evidence-based guidelines re: DBP threshold for treatment intensification | + | + | |||||
Clinical practice | |||||||
Visits typically scheduled by physician with newly diagnosed hypertension patient in first 3 months | + | ||||||
Physician routinely calculates overall cardiovascular risk of patients | + |
Notes:
Negative impact is denoted by a minus (−) sign: increases BP levels, increases odds of uncontrolled BP, decreases change in TCVR, and decreases odds of achieving a reduction in TCVR. Positive impact is denoted by a plus (+) sign: decreases BP levels, decreases odds of uncontrolled BP, increases change in TCVR, and increases odds of achieving a reduction in TCVR.
Abbreviation: ACE, angiotensin converting enzyme.